Metraipolis › archive › dc_82dca6900932

Severe Infection Outcomes With SGLT2 Versus DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Active-Comparator Meta-Analysis of Real-World Cohorts — Europe PMC PMID:42967597

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42967597
DOI
10.1002/edm2.70381
License (as archived)
solo-consultazione
Archived
2026-11-07T17:48:21.016Z
SHA-256 of the archived text
29179fe5639c0d42d1eb778877d61c20a5af5d0b085d0fb1ae2bb00b988cb296
Stable URL of this page
https://metraipolis.com/documento/dc_82dca6900932

How to cite

Severe Infection Outcomes With SGLT2 Versus DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Active-Comparator Meta-Analysis of Real-World Cohorts — Europe PMC PMID:42967597 — Europe PMC (en), https://europepmc.org/article/MED/42967597 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_82dca6900932 (Metraipolis archive dc_82dca6900932, sha256 29179fe5639c0d42d1eb778877d61c20a5af5d0b085d0fb1ae2bb00b988cb296)
BibTeX
@misc{dc82dca6900932,
  title = {Severe Infection Outcomes With SGLT2 Versus DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Active-Comparator Meta-Analysis of Real-World Cohorts — Europe PMC PMID:42967597},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42967597},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_82dca6900932; sha256 29179fe5639c0d42d1eb778877d61c20a5af5d0b085d0fb1ae2bb00b988cb296},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42967597. Agents can read the archived copy with the MCP tool read_document.